Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2/PHASE3
71 participants
INTERVENTIONAL
2012-03-31
2014-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Performance of the CARDIOGARD Cannula
NCT02764645
Safety and Performance Study of the Edwards CENTERA Self-Expanding Transcatheter Heart Valve
NCT01808274
Evaluation of the BARD® True™ Flow Valvuloplasty Perfusion Catheter for Aortic Valve Dilatation
NCT02847546
CTSN Embolic Protection Trial
NCT06027788
CardioCel Tri-leaflet Repair Study
NCT02629328
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CardioGard Cannula
Aortic Cannulas (CardioGard)
Comparison of aortic cannulas during by pass surgery
Reference Cannula
Aortic Cannulas (CardioGard)
Comparison of aortic cannulas during by pass surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Aortic Cannulas (CardioGard)
Comparison of aortic cannulas during by pass surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Non pregnant female
Exclusion Criteria
* Emergency Operation
50 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
CardioGard Medical Ltd.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gil Bolotin, Dr.
Role: PRINCIPAL_INVESTIGATOR
Rambam Health Care Campus
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kerckhoff Klinik
Bad Nauheim, , Germany
Heart Center Leipzig, University of Leipzig
Leipzig, , Germany
Rambam Health Care Campus
Haifa, , Israel
Insel Hospital
Bern, , Switzerland
University Hospital Zurich
Zurich, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CLN0009
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.